首页 > 最新文献

Medical Letter on Drugs and Therapeutics最新文献

英文 中文
Landiolol (Rapiblyk) for short-term rate control in supraventricular tachycardia. 兰地洛尔短期控制室上性心动过速的疗效。
IF 1.4 4区 医学 Q4 PHARMACOLOGY & PHARMACY Pub Date : 2025-05-12 DOI: 10.58347/tml.2025.1728b
{"title":"Landiolol (Rapiblyk) for short-term rate control in supraventricular tachycardia.","authors":"","doi":"10.58347/tml.2025.1728b","DOIUrl":"https://doi.org/10.58347/tml.2025.1728b","url":null,"abstract":"","PeriodicalId":54742,"journal":{"name":"Medical Letter on Drugs and Therapeutics","volume":"67 1728","pages":"75-76"},"PeriodicalIF":1.4,"publicationDate":"2025-05-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144029253","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cologuard Plus - an at-home stool DNA test for colorectal cancer screening. Cologuard Plus -一种用于结肠直肠癌筛查的家庭粪便DNA测试。
IF 1.4 4区 医学 Q4 PHARMACOLOGY & PHARMACY Pub Date : 2025-05-12 DOI: 10.58347/tml.2025.1728a
{"title":"Cologuard Plus - an at-home stool DNA test for colorectal cancer screening.","authors":"","doi":"10.58347/tml.2025.1728a","DOIUrl":"https://doi.org/10.58347/tml.2025.1728a","url":null,"abstract":"","PeriodicalId":54742,"journal":{"name":"Medical Letter on Drugs and Therapeutics","volume":"67 1728","pages":"73-75"},"PeriodicalIF":1.4,"publicationDate":"2025-05-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144052333","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mirikizumab (Omvoh) - an IL-23 antagonist for Crohn's disease. Mirikizumab (Omvoh) -一种克罗恩病的IL-23拮抗剂。
IF 1.4 4区 医学 Q4 PHARMACOLOGY & PHARMACY Pub Date : 2025-05-12 DOI: 10.58347/tml.2025.1728d
{"title":"Mirikizumab (Omvoh) - an IL-23 antagonist for Crohn's disease.","authors":"","doi":"10.58347/tml.2025.1728d","DOIUrl":"https://doi.org/10.58347/tml.2025.1728d","url":null,"abstract":"","PeriodicalId":54742,"journal":{"name":"Medical Letter on Drugs and Therapeutics","volume":"67 1728","pages":"78-80"},"PeriodicalIF":1.4,"publicationDate":"2025-05-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144045209","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Revakinagene taroretcel (Encelto) - a gene therapy for idiopathic macular telangiectasia. Revakinagene taroretcel (Encelto) -一种治疗特发性黄斑毛细血管扩张的基因疗法。
IF 1.4 4区 医学 Q4 PHARMACOLOGY & PHARMACY Pub Date : 2025-04-28 DOI: 10.58347/tml.2025.1727f
{"title":"Revakinagene taroretcel (Encelto) - a gene therapy for idiopathic macular telangiectasia.","authors":"","doi":"10.58347/tml.2025.1727f","DOIUrl":"https://doi.org/10.58347/tml.2025.1727f","url":null,"abstract":"","PeriodicalId":54742,"journal":{"name":"Medical Letter on Drugs and Therapeutics","volume":"67 1727","pages":"e74"},"PeriodicalIF":1.4,"publicationDate":"2025-04-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144058180","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diazoxide choline (Vykat XR) for Prader-Willi syndrome-associated hyperphagia. 二氮氧胆碱(Vykat XR)治疗Prader-Willi综合征相关性贪食症。
IF 1.4 4区 医学 Q4 PHARMACOLOGY & PHARMACY Pub Date : 2025-04-28 DOI: 10.58347/tml.2025.1727e
{"title":"Diazoxide choline (Vykat XR) for Prader-Willi syndrome-associated hyperphagia.","authors":"","doi":"10.58347/tml.2025.1727e","DOIUrl":"https://doi.org/10.58347/tml.2025.1727e","url":null,"abstract":"","PeriodicalId":54742,"journal":{"name":"Medical Letter on Drugs and Therapeutics","volume":"67 1727","pages":"e72-e73"},"PeriodicalIF":1.4,"publicationDate":"2025-04-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144000017","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
In brief: A new indication for tenecteplase (TNKase). 简而言之:tenecteplase (TNKase)的新适应症。
IF 1.4 4区 医学 Q4 PHARMACOLOGY & PHARMACY Pub Date : 2025-04-28 DOI: 10.58347/tml.2025.1727d
{"title":"In brief: A new indication for tenecteplase (TNKase).","authors":"","doi":"10.58347/tml.2025.1727d","DOIUrl":"https://doi.org/10.58347/tml.2025.1727d","url":null,"abstract":"","PeriodicalId":54742,"journal":{"name":"Medical Letter on Drugs and Therapeutics","volume":"67 1727","pages":"71-72"},"PeriodicalIF":1.4,"publicationDate":"2025-04-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144040684","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
In brief: Epinephrine 1 mg nasal spray (neffy). 简而言之:肾上腺素1毫克鼻喷雾剂(neffy)。
IF 1.4 4区 医学 Q4 PHARMACOLOGY & PHARMACY Pub Date : 2025-04-28 DOI: 10.58347/tml.2025.1727c
{"title":"In brief: Epinephrine 1 mg nasal spray (neffy).","authors":"","doi":"10.58347/tml.2025.1727c","DOIUrl":"https://doi.org/10.58347/tml.2025.1727c","url":null,"abstract":"","PeriodicalId":54742,"journal":{"name":"Medical Letter on Drugs and Therapeutics","volume":"67 1727","pages":"71"},"PeriodicalIF":1.4,"publicationDate":"2025-04-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144043656","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Drugs for open-angle glaucoma. 开角型青光眼的药物。
IF 1.4 4区 医学 Q4 PHARMACOLOGY & PHARMACY Pub Date : 2025-04-28 DOI: 10.58347/tml.2025.1727a
{"title":"Drugs for open-angle glaucoma.","authors":"","doi":"10.58347/tml.2025.1727a","DOIUrl":"https://doi.org/10.58347/tml.2025.1727a","url":null,"abstract":"","PeriodicalId":54742,"journal":{"name":"Medical Letter on Drugs and Therapeutics","volume":"67 1727","pages":"65-68"},"PeriodicalIF":1.4,"publicationDate":"2025-04-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144046413","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A fixed-dose combination of meloxicam and rizatriptan (Symbravo) for migraine. 固定剂量美洛昔康和利扎曲坦(Symbravo)联合治疗偏头痛。
IF 1.4 4区 医学 Q4 PHARMACOLOGY & PHARMACY Pub Date : 2025-04-28 DOI: 10.58347/tml.2025.1727b
{"title":"A fixed-dose combination of meloxicam and rizatriptan (Symbravo) for migraine.","authors":"","doi":"10.58347/tml.2025.1727b","DOIUrl":"10.58347/tml.2025.1727b","url":null,"abstract":"","PeriodicalId":54742,"journal":{"name":"Medical Letter on Drugs and Therapeutics","volume":"67 1727","pages":"68-70"},"PeriodicalIF":1.4,"publicationDate":"2025-04-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144006399","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
In brief: Label changes for testosterone products. 简而言之:睾酮产品标签的变化。
IF 1.4 4区 医学 Q4 PHARMACOLOGY & PHARMACY Pub Date : 2025-04-14 DOI: 10.58347/tml.2025.1726d
{"title":"In brief: Label changes for testosterone products.","authors":"","doi":"10.58347/tml.2025.1726d","DOIUrl":"https://doi.org/10.58347/tml.2025.1726d","url":null,"abstract":"","PeriodicalId":54742,"journal":{"name":"Medical Letter on Drugs and Therapeutics","volume":"67 1726","pages":"62-63"},"PeriodicalIF":1.4,"publicationDate":"2025-04-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144050859","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Medical Letter on Drugs and Therapeutics
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1